Author

Zhenye Yang

University of Science and Technology of ChinaORCID 0000-0001-7797-5891Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Aoxing ChengiD· 2 shared Fazhi YuiD· 2 shared Weiqiang YuiD· 2 shared Hanyuan LiuiD· 1 shared Hui Shen· 1 shared Jing Guo· 1 shared Jing Song GuoiD· 1 shared Jinzhou Li· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Aoxing ChengORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 1, 2026

Survivin inhibition induces PD-L1 expression through cGAS stabilization and attenuates antitumor immunity

Yun Liu, Hui Shen, Jinzhou Li…·Fazhi Yu

This study shows that Survivin inhibition increases PD-L1 expression via cGAS stabilization, leading to immune evasion and reduced antitumor immunity.

DOI 10.64898/2026.04.29.721504

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJul 8, 2024

Targeting NOTCH2-JAG1 juxtacrine signaling reverses macrophage-mediated tumor resistance to taxol

Fazhi Yu, Qin Zhou, Tong Zhou…·Zhenye Yang

This study identifies NOTCH2-JAG1 juxtacrine signaling as a target to reverse macrophage-mediated taxane resistance in ovarian cancer by sensitizing tumors to paclitaxel.

1 citation

mousebulk RNA-seq

𝕏 PostBluesky